A comparative, randomized clinical trial of artemisinin/naphtoquine twice daily one day versus artemether/lumefantrine six doses regimen in children and adults with uncomplicated falciparum malaria in Côte d'Ivoire

Malaria Journal

Volumn 8, Issue 1, 2009, Pages

  Toure, Offianan A ^a   Penali, Louis K ^a   Yapi, Jean Didier ^a   Ako, Berenger A ^a   Toure, Walamtchin ^b   Djerea, Kali ^c   Gomez, Genevieve O ^c   Makaila, Oyewole ^d  

^a INSTITUT PASTEUR DE CÔTE D'IVOIRE   (Côte d’Ivoire)

^b Hospital of Bonoua   (Côte d’Ivoire)

^c Health Center of Anonkoua Koute   (Côte d’Ivoire)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ PLUS NAPHTOQUINE; UNCLASSIFIED DRUG; ARTEMISININ; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANOREXIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTHENIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE TRANSMISSION; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; NAUSEA; POLYMERASE CHAIN REACTION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SCHOOL CHILD; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; COMPARATIVE STUDY; COTE D'IVOIRE; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; ISOLATION AND PURIFICATION; PARASITOLOGY; PLASMODIUM FALCIPARUM; RECURRENT DISEASE;

ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; COTE D'IVOIRE; DRUG ADMINISTRATION SCHEDULE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; FLUORENES; FOLLOW-UP STUDIES; HUMANS; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; RECURRENCE; TREATMENT OUTCOME;

EID: 68349152195     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-148     Document Type: Article

References (18)

1. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. JG Breman, Am J Trop Med Hyg 2001 64 1-2 Suppl 1 11 11425172
2. Toward a framework and indicators for monitoring Roll Back Malaria. JHF Remme F Binka D Nabarro, Am J Trop Med Hyg 2001 64 1-2 Suppl 76 84 11425180
3. Making malaria treatment policy in the face of drug resistance. PB Bloland M Ettling, Ann Trop Med Parasitol 1999 93 5 23 10.1080/00034989958753 10492667 (Pubitemid 29358733)
4. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. PJ Guerin P Olliaro F Nosten P Druilhe R Laxminarayan F Binka WL Kilama N Ford NJ White, Lancet Infect Dis 2002 2 564 73 10.1016/S1473-3099(02)00372-9 12206972 (Pubitemid 34966359)
5. Malaria. BM Greenwood K Bojang CJ Whitty GA Targett, Lancet 2005 365 1487 98 10.1016/S0140-6736(05)66420-3 15850634 (Pubitemid 40591695)
6. Global Antimalarial Drug Policies database AFRO. Antimalarial treatment policies for P falciparum and P vivax by country in WHO Africa region. World Health Organization, http://www.who.int/malaria/amdp/amdp-afro.htm (accessed October 10, 2007)
7. A randomized comparative study of naphtoquine, mefloquine and artsunate in the treatment of falciparum malaria. WZ Guo XB Guo QJ Zheng B Tan RJ Chen FZ Ou LC Fu, Zhonghua Yi Xue Za Zhi 2003 83 16 1406 8 14521743
8. Assessment and monitoring of antimalarial drug efficacy for the treatment of uncomplicated falciparium malaria. WHO, WHO/HTM/RBM/ 2003 50
9. An integrated assessment of the clinical safety of artemether- lumefantrine: a new oral fixed-dose combination antimalarial drug. R Bakshi I Hermeling-Fritz I Gathmann E Alteri, Trans R Soc Trop Med Hyg 2000 94 419 424 10.1016/S0035-9203(00)90126-3 11127248
10. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. A Martensson J Stromberg C Sisowath MI Msellem JP Gil SM Montgomery P Olliaro AS Ali A Bjorkman, Clin Infect Dis 2005 41 1079 1086 10.1086/444460 16163624 (Pubitemid 41429468)
11. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. M Mayxay M Khanthavong N Lindegardh S Keola M Barends T Pongvongsa R Yapom A Annerberg S Phompida R Phetsouvanh NJ White PN Newton, Clin Infect Dis 2004 39 1139 1147 10.1086/424512 15486837 (Pubitemid 40169311)
12. Trends in antimalarial drug deployment in sub-13. Saharan Africa. PB Bloland SP Kachur HA Williams, J Exp Biol 2003 206 3761 3769 10.1242/jeb.00637 14506211 (Pubitemid 37365458)
13. Antimalarial treatment with artemisinin combination therapy in Africa. G Malenga A Palmer S Staedke W Kazadi T Mutabingwa E Ansah KI Barnes CJ Whitty, BMJ 2005 331 706 707 16195260 10.1136/bmj.331.7519.706 (Pubitemid 41414933)
14. The microscopic diagnosis of malaria. GT Shute, Principle and practice of malariology Edinburgh: Churchhill Livingstone, Wernsdorfer, McGregor L, 1988 781 814
15. Distinguishing: recrudescence from reinfection in a longitudinal antimalarial drug-efficacy study: Comparison of results based on genotyping of msp-1, msp-2, and glurp. A Cattamanchi D Kyabayinze A Hubbard PJ Rosenthal G Dorsey, Am J Trop Med Hyg 2003 68 133 139 12641400
16. Delaying antimalarial drug resistance with combination chemotherapy. NJ White, Parassitologia 1999 41 1-3 301 308 10697872
17. Artemether-lumefantrine for the treatment of multidrug-resistant falciparum malaria. M van Vugt S Looareesuwan P Wilairatana R McGready L Villegas I Gathmann R Mull A Brockman NJ White F Nosten, Trans R Soc Trop Med Hyg 2000 94 545 548 10.1016/S0035-9203(00)90082-8 11132386 (Pubitemid 30793838)
18. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. A Yeka K Banek N Bakyaita SG Staedke MR Kamya A Talisuna F Kironde SL Nsobya A Kilian M Slater A Reingold PJ Rosenthal F Wabwire-Mangen G Dorsey, PLoS Med. 2005 2 7 e190 10.1371/journal.pmed.0020190 16033307 (Pubitemid 46179276)